Marquis Who's Who Honors Matthew B. Smith, MD, for Contributions to Psychiatry
UNIONDALE, NY / ACCESSWIRE / February 4, 2025 / Marquis Who's Who has honored Matthew B. Smith, MD, for contributions to psychiatry.
Within the field of psychiatry, there are practicing professionals who leave behind a lasting legacy through the patients they have served and the lives they have improved. Dr. Smith is a psychiatrist whose exceptional career has earned acclaim from publishers and organizations such as Marquis Who's Who.
Over his 43 years of practice, Dr. Smith has developed advanced expertise in assisting patients with addictions and mood and personality disorders. Furthermore, he has conducted and published research that has furthered the knowledge and dialogue within psychiatry. Dr. Smith is recognized as a leading figure in psychiatry for the lives he has touched and the insights he has shared.
Early Education and Pursuits
Growing up, Dr. Smith lived in several different countries, as his father worked for the American Foreign Service. He credits his father as a significant role model in his success.
From 1970 to 1971, Dr. Smith completed coursework in theater at Sarah Lawrence College, a private liberal arts college in Yonkers, New York. Pursuing his interest in the humanities, he obtained a Bachelor of Arts in English and philosophy in 1972 from Haverford College, a private liberal arts college in Haverford, Pennsylvania.
Medical Training and Certifications
Dr. Smith began his medical training in a pre-med program at Columbia University, an Ivy League university in New York City. He was accepted into the New York University Grossman School of Medicine and graduated with a degree in medicine in 1981. He completed an internship and residency at New York University from 1981 to 1988, followed by a fellowship in academic psychiatry in 1989. He maintains a medical license in New York and board certification through the American Board of Psychiatry and Neurology.
Thriving Psychiatric Practice
Dr. Smith has practiced psychiatry for over 43 years. He holds expertise in treating patients with adult attention deficit disorder (ADHD), brain injuries, mood and personality disorders and addiction.
Dr. Smith now works as a private practice psychiatrist. For 35 years, his office in New York City has treated a diverse array of patients. His services include individual, group and couples therapy, psychopharmacology and neuropsychiatry. Over his many years of practice, he has cultivated a particular interest in helping those with addiction and mood and personality disorders, honing his techniques and treatments.
Awards and Recognition
Dr. Smith's long and successful career in psychiatry has garnered him attention and acclaim. Previously featured in publications such as The Wall Street Journal and Millennium Magazine, Smith received the Albert Nelson Marquis Lifetime Achievement Award for his contributions to psychiatry.
Academic and Creative Works
Beyond his clinical endeavors, Dr. Smith has made additional contributions to psychiatry through research. He has published his research and findings in various professional papers and opinion articles. He also has a passion for writing and performing poetry, frequently reading his original poems at venues across New York City.
Past Achievements and Future Endeavors
Of all his career achievements, Dr. Smith takes great pride in his involvement in advancing psychiatric research and the papers he has published. He also finds exceptional meaning in his experiences with his patients and the connections he has forged.
Looking ahead, Dr. Smith plans to focus on his creative pursuits. He hopes to publish more non-psychiatric writings, including his poetry, within five to 10 years. He will also continue partaking in his other hobbies, such as traveling and enjoying the arts through visiting museums and galleries. As a celebrated psychiatrist who has touched many lives through his practice, Dr. Smith will continue positively contributing to his patients.
About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms worldwide. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
16 hours ago
- Business Upturn
Dairy Council of California Releases New Edition of The Healthy Eating TABLE, Exploring the Role of Dairy and Nutrition in Healthy Aging
SACRAMENTO, Calif., June 27, 2025 (GLOBE NEWSWIRE) — Dairy Council of California has released the latest edition of The Healthy Eating TABLE , a thought leadership publication that translates, amplifies and bridges the latest evidence in nutrition and dairy science. This edition focuses on the critical role nutrition, including dairy foods, plays in supporting healthy aging. As California's older adult population continues to grow—with one in four Californians projected to be over age 60 by 2040—this issue serves as a timely catalyst for collective action. It aims to spark meaningful conversations among health professionals, educators, and community leaders about the importance of nutrition in promoting vitality and independence as people age. 'Nutrition can be a powerful tool in helping older adults maintain health, mental sharpness and a better quality of life,' says Amy DeLisio, MPH, RDN, CEO of Dairy Council of California. 'This edition of The Healthy Eating TABLE highlights actionable insights that can inform care, shape programs, and support public health strategies.' In addition to in-depth content and research highlights, the edition features a new, evidence-based educational handout designed to support community nutrition education for older adults. Available in English and Spanish, this resource is a versatile tool that can be used in clinics, classrooms, workshops, and outreach events. A partner-driven evaluation and webinar are also planned to enhance its relevance and expand its impact. Access the full June 2025 edition of The Healthy Eating TABLE : About Dairy Council of California Since 1919, Dairy Council of California has been a trusted nutrition organization committed to elevating the health of children and communities. Through education, advocacy, and multisector collaboration, the organization promotes lifelong healthy eating patterns and advances the role of milk and dairy foods in improving nutrition security and supporting sustainable food systems. With more than a century of experience, Dairy Council of California continues to lead with evidence-based nutrition science, education and strategic partnerships to build healthier communities. Learn more at Media Contact: Malynda ParsonsCommunications Program ManagerDairy Council of California [email protected] (916) 633-9333
Time Business News
a day ago
- Time Business News
How Fast Does Zoloft vs Lexapro Start Working?
When it comes to treating depression and anxiety disorders, selective serotonin reuptake inhibitors (SSRIs) like Zoloft (sertraline) and Lexapro (escitalopram) are among the most commonly prescribed medications. Both are effective, but many patients and providers wonder: how fast does zoloft vs lexapro start working? Understanding the onset of action for these medications is important when managing expectations and treatment plans. While both drugs work similarly by increasing serotonin levels in the brain, their speed of effectiveness can vary slightly depending on individual factors. Managing both ADHD and anxiety in adults requires a thoughtful approach to medication. Stimulants like Vyvanse and non-stimulants such as Strattera are often prescribed, but finding the right fit depends on individual needs and medical history. Some adults may benefit from medications that also have anti-anxiety properties, like certain antidepressants or guanfacine. The best ADHD medication for adults with anxiety balances focus and calm without worsening symptoms. Consulting a healthcare provider is essential to tailor treatment effectively, ensuring both conditions are addressed safely. Personalized plans often lead to better outcomes and improved quality of life. Zoloft and Lexapro belong to the SSRI class of antidepressants, which function by increasing the amount of serotonin available in the brain. Serotonin is a neurotransmitter associated with mood regulation, sleep, and anxiety. By blocking the reabsorption (reuptake) of serotonin into neurons, SSRIs help stabilize mood and reduce symptoms of anxiety and depression. However, the physiological changes they initiate in the brain take time, meaning these medications do not work instantly. Zoloft, the brand name for sertraline, is commonly prescribed for major depressive disorder (MDD), generalized anxiety disorder (GAD), panic disorder, social anxiety disorder, and obsessive-compulsive disorder (OCD). After beginning treatment, some patients report mild improvements—such as reduced anxiety or improved sleep—within the first one to two weeks. However, these early benefits are usually subtle. The full therapeutic effects of Zoloft often take 4 to 6 weeks to become evident. In cases of OCD or more severe depression, it may take up to 8 weeks or longer. The timeline may be influenced by factors such as dosage, consistency of use, individual metabolism, and whether the patient is taking other medications. It's crucial to continue taking Zoloft as prescribed, even if benefits are not immediately noticeable. Lexapro, or escitalopram, is also widely used for depression and anxiety disorders. It is generally considered one of the more tolerable SSRIs, with a slightly quicker onset for some users. Many patients report feeling some improvement within 1 to 2 weeks, particularly with anxiety symptoms. This early response may include reduced nervousness, better sleep, and improved energy. Like Zoloft, the full antidepressant effects of Lexapro may take 4 to 6 weeks. However, some research and patient reports suggest that Lexapro may reach peak effectiveness slightly faster in certain individuals compared to Zoloft. For anxiety in particular, Lexapro may offer more rapid relief, making it a preferred first-line treatment in some clinical settings. While both medications share a similar overall timeline, Lexapro may begin relieving anxiety symptoms a bit sooner for some people. This difference is not always dramatic, but in cases where early symptom control is critical, Lexapro may be preferred. Zoloft might take slightly longer to kick in, especially for mood-related symptoms, but it may be more effective in treating a broader range of conditions such as OCD and PTSD. Lexapro, on the other hand, is generally favored for anxiety and has a more favorable side effect profile for many users. Several factors can impact how quickly a person feels the effects of Zoloft or Lexapro: Individual biology: Genetic makeup, brain chemistry, and metabolism affect how a person responds to medication. Genetic makeup, brain chemistry, and metabolism affect how a person responds to medication. Dosage: Starting doses are often low and gradually increased, which can delay noticeable effects. Starting doses are often low and gradually increased, which can delay noticeable effects. Consistency: Taking medication at the same time each day helps maintain stable levels in the bloodstream. Taking medication at the same time each day helps maintain stable levels in the bloodstream. Other medications or conditions: Interactions with other drugs or underlying health issues can slow down or speed up effectiveness. Interactions with other drugs or underlying health issues can slow down or speed up effectiveness. Lifestyle: Sleep, diet, exercise, and substance use can all influence how well SSRIs work. It is common for patients to feel frustrated while waiting for SSRIs like Zoloft or Lexapro to take full effect. During the initial weeks of treatment, it's important to focus on incremental improvements. These might include better sleep, reduced irritability, or slightly improved concentration. Regular follow-ups with a healthcare provider can help track progress and determine if dose adjustments or medication changes are needed. Sometimes, initial side effects—such as nausea, headaches, or increased anxiety—may appear before improvement sets in. These effects often resolve within a few weeks. Patients are encouraged to communicate openly with their doctors and not to stop taking the medication abruptly, as this may cause withdrawal symptoms or worsen the condition. The decision between Zoloft and Lexapro should be made in consultation with a healthcare provider. If quick relief from anxiety is the priority, Lexapro may offer a slightly faster onset. If the individual has symptoms of OCD or PTSD, Zoloft might be the better option. Both medications are generally well-tolerated and highly effective, but the best choice will depend on the individual's symptoms, medical history, and response to treatment. Both Zoloft and Lexapro are effective SSRIs, but their onset of action can vary slightly depending on individual factors. Lexapro may begin to ease anxiety symptoms within the first 1 to 2 weeks for some users, while Zoloft's benefits might take a bit longer to emerge, particularly for depression. Regardless of which medication is prescribed, it's important to be patient and consistent with treatment. With the right support and follow-up, both medications can offer significant improvements in mood, anxiety, and overall quality of life. TIME BUSINESS NEWS
Associated Press
a day ago
- Associated Press
Research Links how Literacy Impacts Health and Wellbeing
SYRACUSE, NY, June 27, 2025 (GLOBE NEWSWIRE) -- Health literacy is essential to improving health outcomes and empowering communities to manage their health and wellbeing. Adult education classrooms have long played a critical role in this empowerment process. But there remains an important question: How have adult education programs and instructors responded to new health care realities, like the increased use of digital technologies and more speakers of other languages who are utilizing the health care system? In a special issue of Adult Literacy Education: The International Journal of Literacy, Language, and Numeracy, researchers studied what is being done to build health literacy among adults with low literacy and language skills. In one study, researchers reviewed what health literacy interventions were in place across formal and informal educational settings for the growing migrant community worldwide and whether they met that population's needs. They found that, depending on the location and cause of migration, a lack of standardization among health literacy interventions created limitations when it came to outcomes. From this, the research team created a set of recommendations to improve the planning and reporting of interventions. In another case study, a team from an adult literacy program in Arizona discusses how it created a mock patient portal that allows adult learners to practice interacting with the health care system digitally and what they learned about the importance of contextualized learning. 'For millions of adults, both in the US and around the globe, the ability to successfully manage their own health care evades them due to low literacy or language skills,' said ProLiteracy President and CEO Mark Vineis. 'It's imperative that adult educators have access to research like this to better understand the needs of adults and to help shape the way they approach instruction to build healthier communities.' This edition of our journal includes further research about language-based health education, a review of the digital health landscape, and a Forum dialog that considers how we think about 'good learners,' 'good patients,' and language. We partner with Rutgers University to publish Adult Literacy Education. The journal editors—Alisa Belzer, Amy Rose, and Heather Brown—are leading researchers in the adult literacy and education field who believe in the importance of research to complement practitioners' experiences, intuition, and professional learning. In the research journal, adult literacy practitioners, researchers, funders, and policymakers can find evidence-based information to guide their practice, prompt important discussions, and build awareness. We publish the free online journal three times per year to share the latest and best research and practices in adult literacy, numeracy, and English language education. Each article in Adult Literacy Education goes through a blind peer-review process to ensure we are publishing the highest quality information that the field can trust and use. By keeping our research free, we ensure that the important information shared in the journal will benefit all adult learners equally. You can find the new issue of Adult Literacy Education at Writers interested in submitting articles for consideration in future issues of the journal can find author guidelines and a submission form on the journal's webpage. About ProLiteracy We are the world's leader in adult education practice, innovating and building the capacity of literacy programs everywhere—from small community-based organizations to large adult education programs and institutions. We serve over 5,000 adult literacy programs annually and work with partners in 28 countries worldwide. By providing comprehensive training and professional learning, accessible research, grant funding, and leading-edge digital and print learning resources through New Readers Press, we advocate for and unleash the power of literacy to transform lives. Contact: Allison Bleyler McDonald
